ORGANOGENESIS HOLDINGS INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $564.2M | $482.0M | $433.1M | $450.9M | $467.4M | $338.3M | $261.0M | $193.4M |
| Cost of Revenue | — | $115.7M | $106.5M | $105.0M | $114.2M | $87.3M | $75.9M | $68.8M |
| Gross Profit | — | $366.3M | $326.7M | $345.9M | $353.2M | $251.0M | $185.0M | $124.6M |
| Gross Margin | — | 76.0% | 75.4% | 76.7% | 75.6% | 74.2% | 70.9% | 64.4% |
| Operating Expenses | ||||||||
| Research & Development | $44.5M | $50.3M | $44.4M | $39.8M | $30.7M | $20.1M | $14.8M | $10.7M |
| SG&A Expense | $326.2M | $294.5M | $269.8M | $283.8M | $250.2M | $204.2M | $200.1M | $162.0M |
| Operating Income | $44.7M | $-1.3M | $12.5M | $22.3M | $72.2M | $26.7M | $-29.9M | $-51.6M |
| Operating Margin | 7.9% | -0.3% | 2.9% | 4.9% | 15.5% | 7.9% | -11.4% | -26.7% |
| Interest Expense | — | — | $2.2M | $2.0M | $7.2M | $11.3M | $9.0M | $10.8M |
| Pretax Income | $47.0M | $-2.8M | $10.4M | $20.3M | $63.1M | $17.8M | $-38.6M | $-64.7M |
| Income Tax Expense | $9.9M | $-3.7M | $5.4M | $4.8M | $-31.1M | $530.0K | $150.0K | $84.0K |
| Net Income | $37.0M | $861.0K | $4.9M | $15.5M | $94.2M | $17.2M | $-38.7M | $-64.8M |
| Net Margin | 6.6% | 0.2% | 1.1% | 3.4% | 20.2% | 5.1% | -14.8% | -33.5% |
| EPS (Basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 | $0.16 | $-0.42 | $-0.94 |
| EPS (Diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.70 | $0.15 | $-0.42 | $-0.94 |
| Shares Outstanding (Basic) | 126.7M | 131.7M | 131.2M | 130.1M | 128.3M | 107.7M | 92.8M | 69.3M |
| Shares Outstanding (Diluted) | 130.2M | 131.7M | 132.7M | 132.4M | 133.7M | 111.4M | 92.8M | 69.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |